Lyell Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.01M Hold
7,276
0.07% 119
2025
Q4
$893K Buy
7,276
+276
+4% +$33.5K 0.06% 120
2025
Q3
$777K Hold
7,000
0.06% 129
2025
Q2
$776K Sell
7,000
-230
-3% -$24.5K 0.06% 130
2025
Q1
$810K Hold
7,230
0.08% 126
2024
Q4
$668K Hold
7,230
0.06% 132
2024
Q3
$606K Hold
7,230
0.06% 136
2024
Q2
$496K Hold
7,230
0.05% 140
2024
Q1
$530K Sell
7,230
-15
-0.2% -$1.15K 0.05% 133
2023
Q4
$587K Sell
7,245
-65
-0.9% -$5.06K 0.07% 128
2023
Q3
$548K Hold
7,310
0.07% 119
2023
Q2
$563K Sell
7,310
-5
-0.1% -$399 0.07% 127
2023
Q1
$607K Buy
7,315
+85
+1% +$7.04K 0.09% 134
2022
Q4
$621K Buy
7,230
+230
+3% +$18.2K 0.1% 127
2022
Q3
$432K Sell
7,000
-247
-3% -$15.6K 0.07% 133
2022
Q2
$448K Hold
7,247
0.07% 135
2022
Q1
$431K Sell
7,247
-203
-3% -$13K 0.06% 144
2021
Q4
$541K Sell
7,450
-258
-3% -$17.8K 0.06% 130
2021
Q3
$538K Buy
7,708
+104
+1% +$7.31K 0.07% 128
2021
Q2
$524K Buy
7,604
+154
+2% +$10.3K 0.06% 132
2021
Q1
$481K Buy
7,450
+450
+6% +$29K 0.07% 131
2020
Q4
$408K Hold
7,000
0.07% 126
2020
Q3
$442K Sell
7,000
-125
-2% -$8.67K 0.08% 98
2020
Q2
$548K Hold
7,125
0.12% 85
2020
Q1
$533K Buy
7,125
+125
+2% +$8.64K 0.16% 82
2019
Q4
$455K Hold
7,000
0.12% 86
2019
Q3
$444K Hold
7,000
0.13% 86
2019
Q2
$473K Hold
7,000
0.14% 90
2019
Q1
$455K Hold
7,000
0.15% 90
2018
Q4
$438K Hold
7,000
0.18% 84
2018
Q3
$540K Buy
+7,000
New +$529K 0.18% 83

Other funds holding GILD

Lyell Wealth Management's GILD Position: Q1 2026 in Review

Lyell Wealth Management held its Gilead Sciences (GILD) position steady in Q1 2026 at 7,276 shares worth $1.01M. The position accounts for 0.07% of the portfolio, ranked #119.

Lyell Wealth Management first reported a position in GILD in Q3 2018 and has held it in 31 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lyell Wealth Management held 7,276 shares of Gilead Sciences worth $1.01M as of Q1 2026.
  • Lyell Wealth Management left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.07% of Lyell Wealth Management's portfolio in Q1 2026, its #119 holding.
  • Lyell Wealth Management first reported a position in Gilead Sciences in Q3 2018 and has held it in 31 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lyell Wealth Management's 13F filing for Q1 2026, filed 7 May 2026.